Disclosure Of Interests In Other Entities [Text Block]

Xspray Pharma - Filing #690673

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31
Disclosure of interests in other entities [text block]	—	—	—		—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	—		—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets	132 229 SEK	—	—	—	—	—	282 065 SEK	—	—	—	—	—	—
Non-current assets	453 200 SEK	—	—	—	—	—	340 838 SEK	—	—	—	—	—	—
Current liabilities	28 851 SEK	—	—	—	—	—	29 966 SEK	—	—	—	—	—	—
Non-current liabilities	560,000 SEK	—	—	—	—	—	1 185 SEK	—	—	—	—	—	—
Revenue	—	—	—	– SEK	—	—	—	—	—	—	– SEK	—	—
Profit (loss)	—	– SEK	– SEK	131 670 SEK	131 670 SEK	– SEK	—	– SEK	– SEK	– SEK	96 698 SEK	96 698 SEK	—
Comprehensive income	—	– SEK	– SEK	131 670 SEK	131 670 SEK	– SEK	—	– SEK	– SEK	– SEK	96 698 SEK	96 698 SEK	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income	—	– SEK	– SEK	– SEK	– SEK	– SEK	—	– SEK	– SEK	– SEK	– SEK	– SEK	—
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	120 166 SEK	—	—	—	—	—	271 881 SEK	—	—	—	—	—	325 598 SEK
Tax expense (income)	—	—	—	– SEK	—	—	—	—	—	—	– SEK	—	—